Ciprofloxacin is used in the treatment of various bacterial infections such as pharyngitis, tonsillitis, pneumonia, sinusitis, ear infections, urinary tract infections, genital tract infections, stomach infections, infections of bones and joints and skin and soft tissue infections. It can also be used in the management of patients with anthrax inhalation exposure.
Ciprofloxacin: Fluoroquinolone antibiotics
Ciprofloxacinworks by blocking the actions of certain bacterial proteins (such as DNA gyrase, topoisomerase IV) which is essential for the bacteria to survive. As a result, it destroys the susceptible bacteria and prevent their further growth and multiplication within the body which helps in reducing the severity of the infection.
Consult your doctor if you experience:
Ciprofloxacin typically starts to work within 1-2 hours of taking a dose and itraconazole 1-2 days after. It can take up to 2-3 days for the full therapeutic effect and sometimes the full effects can be experienced after a relatively low dose. The doses may vary depending on your age, the severity of your viral infections and your age and your ethnic group.
It is recommended to avoid excessive drinking of alcohol as it can increase the risk of side effects.
It is important to let your doctor know about any medications you are taking before starting Ciprofloxacin which could lead to side effects.
Ciprofloxacin is not suitable for use in women or children.
FREQUENTLY as prescribed by the doctor.
Extemetron treatment
The combination of Ciprofloxacin and Tinidazole is indicated for the management of a wide variety of infections caused by susceptible gram-positive and gram-negative organisms along with anaerobes and protozoa.
Ciprofloxacin: Antibiotics (Quinolone antibiotics)
Tinidazole : Antiprotozoals
Ciprofloxacin + Tinidazole effectively manages infection, where ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria. Tinidazole works by killing the parasites and anaerobic bacteria that are responsible for causing infections by damaging their DNA.
Consult your doctor:
Ciprofloxacin + Tinidazole should be taken at the same time each day. The dosages will vary from patient information to about 500mg per day, which is approximately the amount you would need for a single treatment. The old ‘Tinidazole advice to take twice a day’, ‘Twice a day dosage’ and ‘Dosage instructions for children’ dosages were only available in 2011. New information has come to light about how to take ciprofloxacin + Tinidazole, including how to ensure that you are taking this medicine safely and effectively.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Drivers of visionlights:Caution in patients with diabetes, recent stroke, or diabetic ketoacidosis, or diabetic retinopathy, caution in patients taking quinolone therapy, or those taking other non-prescription oral antidiabetic agents.
Patients with a history of muscle disorders (e.g. stroke or myasthenia gravis), seizures, liver enzyme elevation, anticholinergic medication, hypotension, recent cardiac surgery, or uncontrolled blood pressure should discuss the muscle disorders and the quinolone otic agent with their physician before using CNS decoquil. Avoid the use of CNS decoquil in patients with high blood pressure and other hypotensive disorders. CNS decoquil should not be used in patients with diabetes, who are hypertensive, or with certain heart conditions, when other oral antidiabetic agents may increase risk.
Therapy should be started in the presence of clinical worsening or laboratory evidence of toxicity.
Permanent�ciprofloxacin+tizanidine+dapsone+amitryptoferrinThe safety of the use of Ciprofloxacin has not been established in pregnancy. Ciprofloxacin is not indicated for pregnant patients, due to the potential for toxicity. Posological factors include serum calcium levels, liver function tests, and positive fluid/collision studies. Dose reduction with Ciprofloxacin administration has not been studied during the first trimester. The maximum daily dose is up to 2400 mg. Due to potential for acute ototoxicity, patients should be carefully monitored while using Ciprofloxacin. Discontinue if adverse events persist or worsen.
Non-persistent decreased liver functionMay increase levels of serum potassium, resulting in significant and potentially irreversible toxicity (e.g. hypotension, electrolyte disturbances, seizures). Potassium-sparing diuretics such as Risperidone and BUNOWER (astemizole) should be used with caution. May enhance the therapeutic effect of Ciprofloxacin by inhibiting calcium channels. May impair the effectiveness of diuretics such as Risperidone and BUNOWER (amitryptoferrin).
Ciprofloxacin is for use by the gums only.
Oral: 10 mg/kg kg b.i.d. for 3 consecutive days, then 20 mg/kg b.i.d. for 3 consecutive days. Increase to 40 mg/kg b.i.d. if clinically clinically appropriate. If no clinical response is observed 3 days later. Increase to 2 g/kg b.i.d. if clinically appropriate. If no clinical response is observed for more than 4 days, or if clinical signs and symptoms occur more than 4 days later.Renal Function:Gastrointestinal: Hemodialysis for 2 h. Do not exceed 20 mg/kg b.i.d. If no effect is observed for more than 4 days. (See Use in patients with impaired renal function and impaired hepatic function).
Oral: 10 mg/kg b.i.d.
Renal function is evaluated according to the modified Renal Impairment Score (mRIS) test, with 5-HT and androgen binding globulin (UgG), and to creatinine clearance (CrCl). CrCl is calculated as the sum of the upper and lower end-expiratory blood markers. If there is no clinical response, a starting dose of 10 mg/kg b.i.d. is used. If the clinical response is inadequate, a starting dose of 20 mg/kg b.i.d. If CrCl is within 5% the dose is 20 mg/kg b.i.d.
May be taken with or without food.
Known hypersensitivity to ciprofloxacin or any of the excipients. Unnecessary use of the drug.
Renal function should be monitored throughout treatment, even if the patient shows signs of renal impairment. Close monitoring of hepatic function and serum creatinine is important when ciprofloxacin is used in patients with impaired renal function.
See the section in the full prescribing information for full drug and alcohol restrictions.
Breast feeding studies in rats, rabbits and monkeys.Increased serum levels of anticoagulant effects.Decreased clearance of the drug and reduced efficacy at a dose of 10 mg/kg b.i.d., when given in the last few days of pregnancy.
Ciprofloxacin is associated with abnormalities of renal function in some patients, including patients with impaired renal function, a decreased CrCl and impaired hepatic function. There is evidence that ciprofloxacin may have a role in the treatment of severe and occasionally fatal renal failure, and that ciprofloxacin is associated with a reduction in serum creatinine.
Renal function is evaluated according to the mRIS test, with 5-HT and androgen binding globulin (UgG), and to creatinine clearance (CrCl). If CrCl is within 5% the dose is 10 mg/kg b.i.d.
Side effects are rare, but may include: constipation, diarrhea, drowsiness, and fatigue; increased appetite and weight gain; headache; diarrhea, asthenia, urticaria, photosensitivity, tinnitus, dizziness; nausea; vomiting, dry mouth, constipation, diarrhea, and dizziness; palpitations. If any of these effects occur, discontinue therapy.